BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 3087327)

  • 1. Efficacy of tissue plasminogen activator and urokinase in a canine model of prosthetic graft thrombosis.
    Curl GR; Jakubowski JA; Nabseth DC; Bush HL
    Arch Surg; 1986 Jul; 121(7):782-8. PubMed ID: 3087327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beneficial effect of aspirin in maintaining the patency of small-caliber prosthetic grafts after thrombolysis with urokinase or tissue-type plasminogen activator.
    Curl GR; Jakubowski JA; Deykin D; Bush HL
    Circulation; 1986 Sep; 74(3 Pt 2):I21-4. PubMed ID: 3091289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombosed hemodialysis grafts: lyse and wait with tissue plasminogen activator or urokinase compared to mechanical thrombolysis with the Arrow-Trerotola Percutaneous Thrombolytic Device.
    Vogel PM; Bansal V; Marshall MW
    J Vasc Interv Radiol; 2001 Oct; 12(10):1157-65. PubMed ID: 11585881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New thrombolytic brush catheter in thrombosed polytetrafluoroethylene dialysis grafts: preclinical animal study.
    CastaƱeda F; Wyffels PL; Patel JC; Swischuk JL; Li R; Cole BA; Cragg AH
    J Vasc Interv Radiol; 1998; 9(5):793-8. PubMed ID: 9756069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of thrombolysis in infrainguinal bypass grafts.
    Sullivan KL; Gardiner GA; Kandarpa K; Bonn J; Shapiro MJ; Carabasi RA; Smullens S; Levin DC
    Circulation; 1991 Feb; 83(2 Suppl):I99-105. PubMed ID: 1991406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dialysis graft declotting with very low dose urokinase: is it feasible to use "less and wait?".
    Duszak R; Sacks D
    J Vasc Interv Radiol; 1999 Feb; 10(2 Pt 1):123-8. PubMed ID: 10082097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant tissue-type plasminogen activator versus urokinase in peripheral arterial occlusions.
    Dawson KJ; Hamilton G
    Radiology; 1991 Jan; 178(1):283-4. PubMed ID: 1898537
    [No Abstract]   [Full Text] [Related]  

  • 8. Simple canine model of arterial thrombosis with endothelial injury suitable for investigation of thrombolytic agents.
    Badylak SF; Poehlman E; Williams C; Klabunde RE; Turek J; Schoenlein W
    J Pharmacol Methods; 1988 Jul; 19(4):293-304. PubMed ID: 3398538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful declotting of arteriovenous grafts with local infusion of urokinase in hemodialyzed patients.
    Docci D; Turci F; Baldrati L
    Artif Organs; 1986 Dec; 10(6):494-6. PubMed ID: 3800707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulse-spray pharmacomechanical thrombolysis of thrombosed hemodialysis access grafts: long-term experience and comparison of original and current techniques.
    Valji K; Bookstein JJ; Roberts AC; Oglevie SB; Pittman C; O'Neill MP
    AJR Am J Roentgenol; 1995 Jun; 164(6):1495-500; discussion 1501-3. PubMed ID: 7754901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of a prospective, randomized trial of surgery versus thrombolysis for occluded lower extremity bypass grafts.
    Comerota AJ; Weaver FA; Hosking JD; Froehlich J; Folander H; Sussman B; Rosenfield K
    Am J Surg; 1996 Aug; 172(2):105-12. PubMed ID: 8795509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Luminal release of prostacyclin and thromboxane A2 by arteries distal to small-caliber prosthetic grafts.
    Bush HL; Jakubowski JA; Hong SL; McCabe M; Deykin D; Nabseth DC
    Circulation; 1984 Sep; 70(3 Pt 2):I11-5. PubMed ID: 6430592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urokinase treatment preserves endothelial and smooth muscle function in experimental acute arterial thrombosis.
    Whitley D; Gloviczki P; Rhee R; Tazelaar HD; Miller V
    J Vasc Surg; 1996 May; 23(5):851-8; discussion 858-9. PubMed ID: 8667507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transgraft hemorrhage: a serious complication of low-dose thrombolytic therapy.
    Perler BA; Kinnison M; Halden WJ
    J Vasc Surg; 1986 Jun; 3(6):936-8. PubMed ID: 2940380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombolysis with human extrinsic (tissue-type) plasminogen activator in dogs with femoral vein thrombosis.
    Korninger C; Matsuo O; Suy R; Stassen JM; Collen D
    J Clin Invest; 1982 Mar; 69(3):573-80. PubMed ID: 7199539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasminogen acceleration of urokinase thrombolysis.
    Stroughton J; Ouriel K; Shortell CK; Cho JS; Marder VJ
    J Vasc Surg; 1994 Feb; 19(2):298-303; discussion 303-5. PubMed ID: 8114191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental treatment of thrombotic vascular occlusion.
    Labs JD; Caslowitz PL; White RI; Anderson JH; Williams GM
    Lasers Surg Med; 1991; 11(4):363-71. PubMed ID: 1895868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urokinase therapy for thrombosed hemodialysis access grafts.
    Summers S; Drazan K; Gomes A; Freischlag J
    Surg Gynecol Obstet; 1993 Jun; 176(6):534-8. PubMed ID: 8322124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome of intraarterial urokinase for acute vascular occlusion.
    Parent FN; Piotrowski JJ; Bernhard VM; Pond GD; Pabst TS; Bull DA; Hunter GC; McIntyre KE
    J Cardiovasc Surg (Torino); 1991; 32(5):680-9. PubMed ID: 1939333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulsed-spray pharmacomechanical thrombolysis: preliminary clinical results.
    Bookstein JJ; Fellmeth B; Roberts A; Valji K; Davis G; Machado T
    AJR Am J Roentgenol; 1989 May; 152(5):1097-100. PubMed ID: 2705344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.